North Carolina is a leading place for biotech, and a big part of that success comes from GlaxoSmithKline (GSK). This global ...
6h
LONDON, GREATER LONDON, UNITED KINGDOM, October 23, 2024 /EINPresswire / -- The Business Research Company's Early Year-End Sale! Get up to 30% off detailed market research reports-limited time only!
He then served as CEO of Reliant Pharmaceuticals, helping lead the company to its acquisition by GlaxoSmithKline in 2007. He ...
In 2023, the market is anticipated to be valued at USD 26.64 Billion, marking a significant starting point for a decade-long ...
The Industry is on the brink of a substantial surge, with the market size expected to reach USD 100 Million in 2023 and ...
SBI Securities has recommended buying shares of Coal India, Macrotech Developers, Bharti Hexacom, Nippon Life India, Escorts ...
A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...
UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...
Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.
Sep. 25, 2024 — Almost everyone knows about HIV. Fewer people know about its relative, HTLV-1. However, HTLV-1 can cause serious illnesses, including cancer. To develop ways to combat this virus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback